FDA Warning Letter — BP

Case 528250 — FEI 3013606533

The FDA took a Warning Letter action against BP on Jun 29, 2017 (Gallipolis, OH). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
BP
Date
Jun 29, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Gallipolis, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.